NSTK · 01.2026Independent supplement reference
NutriStack
Edition 1.0Updated August 1, 2026

Supplement × Prescription·Evidence index

Lactobacillus Rhamnosus and Metronidazole: what the published research says

PubMed indexes 4 records that name Lactobacillus Rhamnosus and Metronidazole together, either in the title or in an interaction, co-administration, or pharmacokinetic context. Each one is listed below with its study design and, where the abstract states one, the authors’ own conclusion, quoted and linked. This page reports that literature. It does not tell you whether to combine them.

Read this first

An evidence index, not guidance.

Every statement below is attributed to a named, dated, linked source.

This page lists published research relevant to Lactobacillus Rhamnosus and Metronidazole. It deliberately does not state whether the combination is safe, whether it interacts, in which direction, at what dose, or how far apart to take them.

The research

4 studies naming Lactobacillus Rhamnosus and Metronidazole.

Strongest relevance first: papers naming both substances in the title, then human trials and systematic reviews.

Effectiveness of vaginal administration of Lactobacillus rhamnosus following conventional metronidazole therapy: how to lower the rate of bacterial vaginosis recurrences.

The new microbiologica · 2008 · PMID 18843900

Randomized Controlled Trial

“Chi-squared analysis showed a significant difference between the two treatment groups at day 90 (P = 0.05). Safe and effective long-term vaginal administration of Lactobacillus rhamnosus appears to be a useful complementary approach in the management of bacterial vaginosis.”

Marcone et al. · From the abstract

Names both Lactobacillus Rhamnosus and Metronidazole in its title.

No Effect of Lactobacillus rhamnosus GG on Eradication of Colonization by Vancomycin-Resistant Enterococcus faecium or Microbiome Diversity in Hospitalized Adult Patients.

Microbiology spectrum · 2022 · PMID 35475684

Multicenter StudyRandomized Controlled Trial81 participants

“This article showed no effect of the probiotic L. rhamnosus in clearing VREfm from the intestine of patients.”

Rubin et al. · From the abstract

Names Lactobacillus Rhamnosus and Metronidazole together in an interaction, co-administration, or pharmacokinetic context.

Long-term Lactobacillus rhamnosus BMX 54 application to restore a balanced vaginal ecosystem: a promising solution against HPV-infection.

BMC infectious diseases · 2018 · PMID 29304768

Randomized Controlled Trial117 participants

“The consistent percentage of clearance of PAP-smear abnormalities and HPV-clearance obtained in long-term treatment group has been interestingly high and encouraging. Obviously, larger and randomized studies are warranted to confirm these encouraging results, but we believe that eubiosis re-establishment is the key to tackle effectively even HPV-infection.”

Palma et al. · Authors' conclusion

Names Lactobacillus Rhamnosus and Metronidazole together in an interaction, co-administration, or pharmacokinetic context.

Limitations

What this evidence cannot tell you.

Search-based evidence indexes have real limits, and it is worth being explicit about them:

NutriStack

Track what you actually take.

NutriStack is a free iPhone app for organising a supplement routine: what you take, when, and what the published record says about it. Its exploratory interaction checker covers Lactobacillus Rhamnosus, Metronidazole, and several hundred other substances.

The checker is a research and organisation tool, not a clinical decision aid, and its per-pair assessments are excluded from search until they pass claim-level review.

NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.